Skip to main content

Table 3 Mutivariable analysis

From: The expression of TRMT2A, a novel cell cycle regulated protein, identifies a subset of breast cancer patients with HER2 over-expression that are at an increased risk of recurrence

 

CCIH

CCF

RPCI

 

HR

p

HR

p

HR

p

TRMT2A

7.78

0.0046

1.24

0.75

2.958

0.036

T stage

1.06

0.9

2.19

0.012

0.832

0.51

N stage

4.15

0.023

1.44

0.26

1.517

0.27

Grade

0.85

0.7

2

0.24

3.205

0.062

  

n = 57

 

n = 70

 

n = 59

Back to article page

BMC Cancer

ISSN: 1471-2407

Contact us